Press Release Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada MISSISSAUGA, ON, July 15, 2026 /PRNewswire/ — Septa Pharmaceuticals Inc., a rapidly… CISION PRNewswireJuly 15, 2026
Stable Launches StablePay: Instant, Zero-Fee Global Payments App Built on Stablecoin Rails Payments that move at the speed of the internet – send digital… CISION PRNewswireJuly 15, 2026
Hycroft Appoints Michael Deal as Chief Operating Officer WINNEMUCCA, Nev., July 15, 2026 /PRNewswire/ — Hycroft Mining Holding Corporation (Nasdaq:… CISION PRNewswireJuly 15, 2026
HIGHWAY HOLDINGS REPORTS FISCAL FOURTH QUARTER AND FULL YEAR 2026 RESULTS HONG KONG, July 15, 2026 /PRNewswire/ — Highway Holdings Limited (Nasdaq: HIHO, the… CISION PRNewswireJuly 15, 2026
BNY Reports Second Quarter 2026 Results NEW YORK, July 15, 2026 /PRNewswire/ — The Bank of New York… CISION PRNewswireJuly 15, 2026
Initiative on Joint Promotion of World Cultural Heritage Launched in Chongzuo, China CHONGZUO, China, July 15, 2026 /PRNewswire/ — This is a report from… CISION PRNewswireJuly 15, 2026
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 15, 2026 /PRNewswire/ — Harbour… CISION PRNewswireJuly 15, 2026
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30 – ASC48 is a potentially first-in-class oral small molecule GIPR agonist. –… CISION PRNewswireJuly 15, 2026
